Oak Thistle’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35M Sell
6,046
-15,967
-73% -$6.37M 0.22% 181
2026
Q2
$8.51M Buy
+22,013
New +$8.16M 0.82% 5
2025
Q4
– Sell
-4,078
Closed -$1.32M – 542
2025
Q3
$1.32M Buy
+4,078
New +$1.27M 0.2% 200
2024
Q4
– Sell
-3,744
Closed -$1.95M – 443
2024
Q3
$1.95M Buy
+3,744
New +$2M 0.63% 19
2024
Q1
– Sell
-2,022
Closed -$953K – 364
2023
Q4
$953K Sell
2,022
-3,351
-62% -$1.55M 0.27% 139
2023
Q3
$2.34M Buy
5,373
+3,109
+137% +$1.41M 0.69% 3
2023
Q2
$1.01M Buy
+2,264
New +$1.04M 0.53% 40
2022
Q3
– Sell
-949
Closed -$458K – 146
2022
Q2
$458K Buy
+949
New +$469K 0.88% 14

Other funds holding ELV

Oak Thistle's ELV Position: Q3 2026 in Review

Oak Thistle reduced its Elevance Health (ELV) stake by 73% in Q3 2026, selling an estimated $6.37M and leaving 6,046 shares worth $2.35M. The position accounts for 0.22% of the portfolio, ranked #181.

Oak Thistle first reported a position in ELV in Q2 2022 and has held it in 8 quarters since. The position peaked at $8.51M in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Oak Thistle held 6,046 shares of Elevance Health worth $2.35M as of Q3 2026.
  • Oak Thistle sold 15,967 Elevance Health shares in Q3 2026, an estimated $6.37M.
  • Elevance Health made up 0.22% of Oak Thistle's portfolio in Q3 2026, its #181 holding.
  • Oak Thistle first reported a position in Elevance Health in Q2 2022 and has held it in 8 quarters since.
  • Oak Thistle's Elevance Health position peaked at $8.51M in Q2 2026.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.